Gažová Andrea, et al.
Journal of traditional and complementary medicine, 2019
Abstract
Aim
The safety and effectiveness of a preparation containing a mix of Cucurbita Pepo Seed extract, Equisetum arvense and Linum usitatissimum - Flax A (CELcomplex®) on stress urinary incontinence (SUI) was evaluated in female patients recruited from 20 urological and gynaecological outpatient clinics in Slovakia.
Methods
A total of 86 women aged from 32 to 88 with SUI (grade 1 = 44, grade 2 = 42) were enrolled in the study and followed-up for six weeks (point 1) and twelve weeks (point 2). The primary outcome of the study was evaluated by changes in day-time and nocturnal urinary frequency (bathroom visits) and urinary incontinence episodes (leaks). Also, adverse events were quantified as well as the self-perceived effectiveness of the treatment. Research Ethics Board approval was obtained for this study.
Results
After 12 weeks of treatment there was a 30% (grade 1 SUI, p < 0.01), and 35% (grade 2 SUI, p < 0.01) improvement in urinary incontinence episodes, a 40% (grade 1 SUI, p < 0.01) and 26% (grade 2 SUI, p < 0.01) improvement in day-time urination frequency and 64% (grade 1 SUI, p < 0.01) and 54% (grade 2 SUI, p < 0.01) improvement in nocturnal urinary frequency. Reported side effects were: headache (3.5%), flatulence (4.1%) and gastrointestinal discomfort (3%). A total of 89.4 % of women in the study reported no side effects from this therapy and 97% acknowledged improvement of symptoms.
Conclusion
This clinical study demonstrated that a 12 week treatment with a mix of Cucurbita Pepo Seed extract, Equisetum arvense and Linum usitatissimum - Flax A (CELcomplex®) is highly effective on stress urinary incontinence (SUI) with minimum adverse events. Further studies may be needed in order to determine the effectiveness and efficacy of this phytotherapy in other populations.
Keywords
Pumpkin seed; Stress urinary incontinence – SUI; Women.
| PMID: | 30963048 |
|---|---|
| DOI: | 10.1016/j.jtcme.2017.10.005 |
| PMCID (Free PMC Article): | PMC6435946 |
| Category: | Urinary Tract |
The best supplements with Equisetum Arvense, Linum Usitatissimum or Cucurbita Pepo in Urinary Tract category:
- Kidney Cleanse, 90 Veggie Caps (Now Foods) - A healthy urinary tract is essential for maintaining the body's normal fluid balance and for cleansing the body of metabolic wastes. It contains among others: Equisetum Arvense.
Articles similar to "Clinical Study of Effectiveness and Safety of CELcomplex ® Containing Cucurbita Pepo Seed Extract and Flax and Casuarina on Stress Urinary Incontinence in Women."
- The significance of Equisetum Arvense for Urinary Tract: Urox Containing Concentrated Extracts of Crataeva Nurvala Stem Bark, Equisetum Arvense Stem and Lindera Aggregata Root, in the Treatment of Symptoms of Overactive Bladder and Urinary Incontinence: A Phase 2, Randomised, Double-Blind Placebo Controlled Trial. ( Storage lower urinary tract symptoms (LUTS) including overactive bladder (OAB) and urinary incontinence (UI) affect millions of people worldwide, significantly impacting quality of life... The outcome of this study demonstrated both statistical significance and clinical relevance in reducing symptoms of OAB, urinary frequency and/or urgency and incontinence. The demonstrated viability of the herbal combination to serve as an effective treatment, with minimal side-effects, warrants further longer term research and consideration by clinicians. )
- The impact of Equisetum Arvense on Urinary Tract: Randomized, Double-Blind Clinical Trial to Assess the Acute Diuretic Effect of Equisetum Arvense (Field Horsetail) in Healthy Volunteers. (In this double-blind, randomized clinical trial, 36 healthy male volunteers were randomly distributed into three groups (n = 12) that underwent a three-step treatment... The outcome of this study demonstrated both statistical significance and clinical relevance in reducing symptoms of OAB, urinary frequency and/or urgency and incontinence. The demonstrated viability of the herbal combination to serve as an effective treatment, with minimal side-effects, warrants further longer term research and consideration by clinicians. )